Table 1.
PS | |
---|---|
Number of patients | 43 |
Male (%) | 58.00 |
Mean age | 39 |
DLCO (mean ± SD) | 69.5 ± 15.7 |
Chest X-ray stage, (PS, stage I/II/III/IV) | 8/30/3/2 |
>20% Lymphocytes in BALF (% patients) | 73% |
CD4/CD8 >3,5 (% patients) | 67% |
Lymphadenopathy (% patients) | 88% |
Granuloma proven (biopsy) | 28% |
PS: pulmonary sarcoidosis; DLCO: percentage of predicted carbon monoxide lung diffusion capacity.